Skip to main content

Advertisement

Log in

Development and validation of an automatic classification algorithm for the diagnosis of Alzheimer’s disease using a high-performance interpretable deep learning network

  • Neuro
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To develop and validate an automatic classification algorithm for diagnosing Alzheimer’s disease (AD) or mild cognitive impairment (MCI).

Methods and materials

This study evaluated a high-performance interpretable network algorithm (TabNet) and compared its performance with that of XGBoost, a widely used classifier. Brain segmentation was performed using a commercially approved software. TabNet and XGBoost were trained on the volumes or radiomics features of 102 segmented regions for classifying subjects into AD, MCI, or cognitively normal (CN) groups. The diagnostic performances of the two algorithms were compared using areas under the curves (AUCs). Additionally, 20 deep learning–based AD signature areas were investigated.

Results

Between December 2014 and March 2017, 161 AD, 153 MCI, and 306 CN cases were enrolled. Another 120 AD, 90 MCI, and 141 CN cases were included for the internal validation. Public datasets were used for external validation. TabNet with volume features had an AUC of 0.951 (95% confidence interval [CI], 0.947–0.955) for AD vs CN, which was similar to that of XGBoost (0.953 [95% CI, 0.951–0.955], p = 0.41). External validation revealed the similar performances of two classifiers using volume features (0.871 vs. 0.871, p = 0.86). Likewise, two algorithms showed similar performances with one another in classifying MCI. The addition of radiomics data did not improve the performance of TabNet. TabNet and XGBoost focused on the same 13/20 regions of interest, including the hippocampus, inferior lateral ventricle, and entorhinal cortex.

Conclusions

TabNet shows high performance in AD classification and detailed interpretation of the selected regions.

Clinical relevance statement

Using a high-performance interpretable deep learning network, the automatic classification algorithm assisted in accurate Alzheimer’s disease detection using 3D T1-weighted brain MRI and detailed interpretation of the selected regions.

Key Points

• MR volumetry data revealed that TabNet had a high diagnostic performance in differentiating Alzheimer’s disease (AD) from cognitive normal cases, which was comparable with that of XGBoost.

• The addition of radiomics data to the volume data did not improve the diagnostic performance of TabNet.

• Both TabNet and XGBoost selected the clinically meaningful regions of interest in AD, including the hippocampus, inferior lateral ventricle, and entorhinal cortex.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AD:

Alzheimer’s disease

ADNI:

Alzheimer Disease Neuroimaging Initiative

AIBL:

Australian Imaging Biomarkers and Lifestyle Study of Aging

AUC:

Area under the curve

CDR:

Clinical dementia rating

CN:

Cognitive normal

MCI:

Mild cognitive impairment

References

  1. Nichols E, Szoeke CE, Vollset SE et al (2019) Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:88–106

    Article  Google Scholar 

  2. Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol 6:734–746

    Article  PubMed  Google Scholar 

  4. McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269

    Article  PubMed  PubMed Central  Google Scholar 

  5. Fink HA, Linskens EJ, Silverman PC et al (2020) Accuracy of biomarker testing for neuropathologically defined Alzheimer disease in older adults with dementia: a systematic review. Ann Intern Med 172:669–677

    Article  PubMed  Google Scholar 

  6. Yamashita R, Nishio M, Do RKG, Togashi K (2018) Convolutional neural networks: an overview and application in radiology. Insights Imaging 9:611–629

    Article  PubMed  PubMed Central  Google Scholar 

  7. Suh C, Shim W, Kim S et al (2020) Development and validation of a deep learning–based automatic brain segmentation and classification algorithm for Alzheimer disease using 3D T1-weighted volumetric images. AJNR Am J Neuroradiol 41:2227–2234

  8. Arık SO, Pfister T (2020) Tabnet: attentive interpretable tabular learning. arXiv:190807442v5

  9. Chen T, Guestrin C (2016) Xgboost: a scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining, pp 785–794. https://doi.org/10.1145/2939672.2939785

  10. Jack CR Jr, Albert MS, Knopman DS et al (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:257–262

  11. Mueller SG, Weiner MW, Thal LJ et al (2005) The Alzheimer’s disease neuroimaging initiative. Neuroimaging Clin N Am 15:869–877

    Article  PubMed  PubMed Central  Google Scholar 

  12. Fischl B (2012) FreeSurfer. Neuroimage 62:774–781

  13. Van Griethuysen JJ, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Can Res 77:e104–e107

    Article  Google Scholar 

  14. Shwartz-Ziv R, Armon A (2022) Tabular data: deep learning is not all you need. Inf Fusion 81:84–90

    Article  Google Scholar 

  15. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845

    Article  CAS  PubMed  Google Scholar 

  16. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35

    Article  CAS  PubMed  Google Scholar 

  17. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodol) 57:289–300

    Google Scholar 

  18. Ribeiro MT, Singh S, Guestrin C (2016) Why should I trust you? Explaining the predictions of any classifier. In Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining, pp 1135–1144. https://doi.org/10.48550/arXiv.1602.04938

  19. Kong H-J (2019) Managing unstructured big data in healthcare system. Healthc Inform Res 25:1–2

  20. Jo T, Nho K, Saykin AJ (2019) Deep learning in Alzheimer’s disease: diagnostic classification and prognostic prediction using neuroimaging data. Front Aging Neurosci 20(11):220

    Article  Google Scholar 

  21. Yang H, Xu H, Li Q et al (2019) Study of brain morphology change in Alzheimer’s disease and amnestic mild cognitive impairment compared with normal controls. Gen Psychiatry 32(2):e100005

  22. Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC, AsDN I (2011) Amygdala atrophy is prominent in early Alzheimer’s disease and relates to symptom severity. Psychiatry Res Neuroimaging 194:7–13

    Article  Google Scholar 

  23. Choi JD, Moon Y, Kim H-J, Yim Y, Lee S, Moon W-J (2022) Choroid plexus volume and permeability at brain MRI within the Alzheimer disease clinical spectrum. Radiology 304(3):635–645

    Article  PubMed  Google Scholar 

  24. Schippers MC, Bruinsma B, Gaastra M et al (2017) Deep brain stimulation of the nucleus accumbens core affects trait impulsivity in a baseline-dependent manner. Front Behav Neurosci 11:52

    Article  PubMed  PubMed Central  Google Scholar 

  25. Pievani M, Bocchetta M, Boccardi M et al (2013) Striatal morphology in early-onset and late-onset Alzheimer’s disease: a preliminary study. Neurobiol Aging 34:1728–1739

    Article  CAS  PubMed  Google Scholar 

  26. Nie X, Sun Y, Wan S et al (2017) Subregional structural alterations in hippocampus and nucleus accumbens correlate with the clinical impairment in patients with Alzheimer’s disease clinical spectrum: parallel combining volume and vertex-based approach. Front Neurol 8:399

    Article  PubMed  PubMed Central  Google Scholar 

  27. Feng Q, Ding Z (2020) MRI radiomics classification and prediction in Alzheimer’s disease and mild cognitive impairment: a review. Curr Alzheimer Res 17:297–309

    Article  CAS  PubMed  Google Scholar 

  28. Ranjbar S, Velgos SN, Dueck AC, Geda YE, Mitchell JR, AsDN I (2019) Brain MR radiomics to differentiate cognitive disorders. J Neuropsychiatry Clin Neurosci 31:210–219

    Article  PubMed  PubMed Central  Google Scholar 

  29. Achterberg HC, van der Lijn F, den Heijer T et al (2014) Hippocampal shape is predictive for the development of dementia in a normal, elderly population. Hum Brain Mapp 35:2359–2371

    Article  PubMed  Google Scholar 

  30. Sørensen L, Igel C, Liv Hansen N et al (2016) Early detection of Alzheimer’s disease using M RI hippocampal texture. Hum Brain Mapp 37:1148–1161

    Article  PubMed  Google Scholar 

  31. Won SY, Park YW, Park M, Ahn SS, Kim J, Lee S-K (2020) Quality reporting of radiomics analysis in mild cognitive impairment and Alzheimer’s disease: a roadmap for moving forward. Korean J Radiol 21:1345–1354

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ferreira D, Nordberg A, Westman E (2020) Biological subtypes of Alzheimer disease: a systematic review and meta-analysis. Neurology 94:436–448

    Article  PubMed  PubMed Central  Google Scholar 

  33. Ferreira D, Verhagen C, Hernández-Cabrera JA et al (2017) Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications. Sci Rep 7:1–13

    Article  Google Scholar 

Download references

Funding

This work was supported by the National Research Foundation of Korea (NRF-2021R1C1C1014413 to Chong Hyun Suh).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chong Hyun Suh.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Chong Hyun Suh, M.D.

Conflict of interest

Hyun Woo Oh, M.S.; Kim Jingyoung, M.S.; and Jinkyeong Sung, M.D., Ph.D. are employees of VUNO Inc. The authors report no other conflicts of interest, and the present study has not been presented elsewhere.

Statistics and biometry

One of the authors has significant statistical expertise.

Informed consent

Written informed consent was not required due to the retrospective nature of the study.

Ethical approval

This study was approved by the institutional review board of Asan Medical Center.

Methodology

• Retrospective

• Diagnostic or prognostic study

• Performed at one institution

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 185 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, H.Y., Shim, W.H., Suh, C.H. et al. Development and validation of an automatic classification algorithm for the diagnosis of Alzheimer’s disease using a high-performance interpretable deep learning network. Eur Radiol 33, 7992–8001 (2023). https://doi.org/10.1007/s00330-023-09708-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-09708-8

Keywords

Navigation